Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bettina Nørby1, Andreas Røder2, Charlotte Graugaard-Jensen3

  • 1Afdeling for Urinvejskirurgi, Sygehus Lillebælt, Vejle Sygehus.

Ugeskrift for Laeger
|April 14, 2023
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Substaging and Stratified Treatment of T1 Bladder Cancer - a Nationwide Register-Based Study.

European urology open science·2026
Same author

Histopathological Advantages of En Bloc Resection in Non-muscle-invasive Bladder Cancer: A Multinational Randomised Controlled Clinical Trial.

European urology open science·2026
Same author

Corrigendum to "Robot-assisted Kidney Transplantation: The 8-year European experience" [Eur. Urol. 87(4) (2025) 468-475].

European urology·2026
Same author

Outcomes after kidney transplantation in patients with urinary diversions or bladder augmentations: A 20-year nationwide study.

Investigative and clinical urology·2026
Same author

IMPACT-Introduction of Mycotic Prophylaxis At Cystectomy Trial: perioperative mycotic prophylaxis with fluconazole to reduce postoperative complications following cystectomy-study protocol for a national multi-center, double-blinded, placebo-controlled, randomized clinical trial.

Trials·2026
Same author

Pilot Survey about the perspective on Generation Z among European leaders in Urology: Challenges in educating Generation Z.

Urologia internationalis·2026

Benign prostatic hyperplasia (BPH) treatments vary from medication to surgery. This review focuses on current Danish treatment options, emphasizing patient evaluation and shared decision-making for optimal BPH management.

Area of Science:

  • Urology
  • Surgical Technology

Background:

  • Benign prostatic hyperplasia (BPH) is a common condition requiring diverse treatment strategies.
  • Treatment options range from conservative medical management to surgical interventions like open prostatectomy.
  • Advancements in surgical technologies offer new therapeutic avenues for BPH.

Approach:

  • This review evaluates the current landscape of BPH treatments available in Denmark.
  • It synthesizes information on established and emerging therapeutic modalities.
  • Focus is placed on the practical application of treatments within the Danish healthcare system.

Key Points:

  • Transurethral resection of the prostate (TURP) is the gold standard for prostates <80 cc.
  • Enucleation and simple open prostatectomy are preferred for larger prostates (>80 cc).

Related Experiment Videos

  • Thorough pre-treatment patient evaluation is crucial for selecting the appropriate BPH management strategy.

    • Conclusions:

    • The choice of BPH treatment should be individualized based on prostate size and patient factors.
    • Shared decision-making between clinician and patient is essential for successful treatment outcomes.
    • Denmark offers a spectrum of BPH treatments, from medication to advanced surgical techniques.